Sunitinib Non Small Cell Lung Cancer Patients Over 70

NCT00864721 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Sutent

Sponsor

US Oncology Research

Collaborators

[object Object]